Abstract:ObjectiveTo evaluate the usefulness of skin ultrasound and acoustic radiation force impulse (ARFI) quantification in diffuse cutaneous systemic sclerosis (dcSSc).Patients and methods28 patients with dcSSc, and 15 age gender matched normal controls were recruited. Skin echogenicity, thickness, and ARFI quantification were measured by ultrasound at 17 sites corresponding to the modified Rodnan skin score (mRSS) in each participant. Compared with controls, skin echogenicity of dcSSc patients was classified into i… Show more
“…In recent years, shear-wave elastography (SWE) has been investigated as a quantitative and operatorindependent tool to evaluate skin stiffness [7][8][9]. Shearwave velocity (SWV) values reflect tissue stiffness: the stiffer the tissue, the faster the shear-waves propagate.…”
Background: Measurement of skin involvement is essential for the diagnosis and assessment of prognosis and disease progression in systemic sclerosis (SSc). The modified Rodnan skin score (mRSS) is the gold standard measure of skin thickness, but it has been criticised for the lack of objectivity, poor inter-observer reproducibility and lack of sensitivity to change. Recently, shear-wave elastography (SWE) emerged as a promising tool for the objective and quantitative assessment of the skin in SSc patients. However, no studies have evaluated its sensitivity to change over time. Objective: To assess changes in skin stiffness in SSc patients using SWE during a 5-year follow-up. Methods: Skin stiffness [i.e. shear-wave velocity values (SWV) in metres per second] was assessed by SWE ultrasound (using virtual touch image quantification) at the 17 sites of the mRSS, in each participant, at baseline and follow-up. mRSS was performed at both time points. Differences between groups were analysed using the related-samples Wilcoxon signed-rank test and the Mann-Whitney U test. Results: We included 21 patients [85.7% females; mean age 56.3 (10.4) years at baseline, 57.1% with limited SSc] and 15 healthy controls [73.3% females; mean age 53.6 (14.1) years)]. The median follow-up was 4.9 (0.4) years. Skin stiffness decreased significantly at all Rodnan sites (p ≤ 0.001) (except in the fingers), in SSc patients, over time. The same phenomenon occurred in controls, but to a lesser degree, in terms of percentage change. The percentage reduction in skin stiffness varied in the different Rodnan sites and in different phases of the disease. In addition, SWV values also decreased significantly in 15/16 skin sites with local normal Rodnan at baseline, whereas local Rodnan skin score only changed significantly in the upper arm (p = 0.046) and forearm (p = 0.026). Conclusion: This study provides first-time evidence suggesting that skin SWV values are more sensitive to change over time than mRSS and reduce significantly over time in SSc and normal controls.
“…In recent years, shear-wave elastography (SWE) has been investigated as a quantitative and operatorindependent tool to evaluate skin stiffness [7][8][9]. Shearwave velocity (SWV) values reflect tissue stiffness: the stiffer the tissue, the faster the shear-waves propagate.…”
Background: Measurement of skin involvement is essential for the diagnosis and assessment of prognosis and disease progression in systemic sclerosis (SSc). The modified Rodnan skin score (mRSS) is the gold standard measure of skin thickness, but it has been criticised for the lack of objectivity, poor inter-observer reproducibility and lack of sensitivity to change. Recently, shear-wave elastography (SWE) emerged as a promising tool for the objective and quantitative assessment of the skin in SSc patients. However, no studies have evaluated its sensitivity to change over time. Objective: To assess changes in skin stiffness in SSc patients using SWE during a 5-year follow-up. Methods: Skin stiffness [i.e. shear-wave velocity values (SWV) in metres per second] was assessed by SWE ultrasound (using virtual touch image quantification) at the 17 sites of the mRSS, in each participant, at baseline and follow-up. mRSS was performed at both time points. Differences between groups were analysed using the related-samples Wilcoxon signed-rank test and the Mann-Whitney U test. Results: We included 21 patients [85.7% females; mean age 56.3 (10.4) years at baseline, 57.1% with limited SSc] and 15 healthy controls [73.3% females; mean age 53.6 (14.1) years)]. The median follow-up was 4.9 (0.4) years. Skin stiffness decreased significantly at all Rodnan sites (p ≤ 0.001) (except in the fingers), in SSc patients, over time. The same phenomenon occurred in controls, but to a lesser degree, in terms of percentage change. The percentage reduction in skin stiffness varied in the different Rodnan sites and in different phases of the disease. In addition, SWV values also decreased significantly in 15/16 skin sites with local normal Rodnan at baseline, whereas local Rodnan skin score only changed significantly in the upper arm (p = 0.046) and forearm (p = 0.026). Conclusion: This study provides first-time evidence suggesting that skin SWV values are more sensitive to change over time than mRSS and reduce significantly over time in SSc and normal controls.
“…All participants were recruited from a cross-sectional evaluation previously described elsewhere. 9 In this longitudinal study we included 21 of the original 26 patients (3 died and 2 were lost to follow-up) and, 15 of the 17 initial healthy controls (1 died, and 1 was lost to follow-up). The healthy controls were recruited among hospital staff and patient's family members, using as exclusion criteria, any diagnosis of other skin disorder (e.g.…”
Objective To assess changes in skin stiffness in SSc patients using SWE during a five-year follow-up. Methods Skin stiffness [i.e. shear-wave velocity values (SWV) in m/s] was assessed by SWE ultrasound (using virtual touch image quantification) at the 17 sites of the mRSS, in each participant, at baseline and follow-up. mRSS was performed at both time points. Differences between groups were analysed using the related-samples Wilcoxon Signed Rank test and the Mann–Whitney U test. Results We included 21 patients [85.7% females; mean age 56.3 (10.4) years at baseline, 57.1% with limited SSc] and, 15 healthy controls [73.3% females; mean age 53.6 (14.1) years)]. The median follow-up was 4.9 (0.4) years. Skin stiffness decreased significantly at all Rodnan sites (p≤0.001), (except in the fingers), in SSc patients, over time. The same phenomenon occurred in controls, but to a lesser degree, in terms of percentage change. The percentage reduction in skin stiffness varied in the different Rodnan sites and in different phases of the disease. In addition, SWV values also decreased significantly in 15/16 skin sites with local normal Rodnan at baseline, whereas local Rodnan skin score only changed significantly in the upperarm (p=0.046) and forearm (p=0.026). Conclusion This study provides first-time evidence suggesting that skin SWV values are more sensitive to change over time than mRSS, and reduce significantly over time in SSc and normal controls.
“…All participants were recruited from a cross-sectional evaluation previously described elsewhere. 9 In this longitudinal study we included 21 of the original 26 patients (3 died and 2 were lost to follow-up) and, 15 of the 17 initial healthy controls (1 died, and 1 was lost to follow-up). All participants were submitted to a clinical and ultrasound evaluation at baseline and at follow-up, a median of 4.9 (0.4) years later.…”
Section: Participantsmentioning
confidence: 99%
“…In recent years, shear-wave elastography (SWE) has been investigated as a quantitative and operator-independent tool to evaluate skin stiffness. [7][8][9] Shear-wave velocity (SWV) values reflect tissue stiffness: the stiffer the tissue, the faster the shear-waves propagate. SWE may, therefore, provide a novel opportunity to objectively assess fibrosis -a crucial feature in the complex process of skin involvement in SSc.…”
Section: Introductionmentioning
confidence: 99%
“…10,11 Cross sectional studies have shown that SWV values are significantly higher in SSc patients than in controls, in almost all of the Rodnan sites. [7][8][9] Interestingly, clinically unaffected skin of patients with SSc could also be differentiated from the skin of healthy comparators. 7,8 Two previous studies have shown excellent reproducibility for SWV measurements, with inter-rater intraclass correlation coefficients (ICCs) ranging from 0.48 (phalanx) to 0.91 (upper arm).…”
Objective To assess changes in skin stiffness in SSc patients using SWE during a five-year follow-up. Methods Skin stiffness [i.e. shear-wave velocity values (SWV) in m/s] was assessed by SWE ultrasound (using virtual touch image quantification) at the 17 sites of the mRSS, in each participant, at baseline and follow-up. mRSS was performed at both time points. Differences between groups were analysed using the related-samples Wilcoxon Signed Rank test and the Mann–Whitney U test. Results We included 21 patients [85.7% females; mean age 56.3 (10.4) years at baseline, 57.1% with limited SSc] and, 15 healthy controls [73.3% females; mean age 53.6 (14.1) years)]. The median follow-up was 4.9 (0.4) years. Skin stiffness decreased significantly at all Rodnan sites (p≤0.001), (except in the fingers), in SSc patients, over time. The same phenomenon occurred in controls, but to a lesser degree, in terms of percentage change. The percentage reduction in skin stiffness varied in the different Rodnan sites and in different phases of the disease. In addition, SWV values also decreased significantly in 15/16 skin sites with local normal Rodnan at baseline, whereas local Rodnan skin score only changed significantly in the upperarm (p=0.046) and forearm (p=0.026). Conclusion This study provides first-time evidence suggesting that skin SWV values are more sensitive to change over time than mRSS, and reduce significantly over time in SSc and normal controls.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.